Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07301281

Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia

Cluster Randomized Controlled Trial of the "Mittin" Intervention in Addis Ababa, Ethiopia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
2,715 (estimated)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Female
Age
15 Years – 49 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if the "Mittin" intervention can improve women's ability to manage their fertility in line with their preferences among women aged 15-49 using hormonal contraceptives or intrauterine devices and attending public health centers in Addis Ababa, Ethiopia. The main question it aims to answer is: Does the Mittin intervention increase preference-aligned fertility management, contraceptive method satisfaction, and preferred contraceptive method use among participants compared to standard care? Researchers will compare women's outcomes in health centers providing the Mittin intervention to women's outcomes in health centers that offer standard care to see if Mittin improves women's ability to act in line with their contraceptive preferences. Participants will * Receive either standard contraception services (control arm) or enhanced services (intervention arm) * Participate in a survey at the beginning of the study * Participate in surveys 4 and 8 months later

Conditions

Interventions

TypeNameDescription
BEHAVIORALMittinMittin intervention consists of the following components: 1. Educational posters and handouts to raise awareness of the right to contraceptive choice and to switch methods if side effects become intolerable 2. Decision support tools for providers to aid women in weighing the risks and benefits of potential side effects during in-person counseling 3. On-demand and proactive virtual side effects counseling and referrals via a call center.

Timeline

Start date
2026-02-01
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2025-12-24
Last updated
2025-12-24

Locations

1 site across 1 country: Ethiopia

Source: ClinicalTrials.gov record NCT07301281. Inclusion in this directory is not an endorsement.